Representative Bruce Westerman (R-Arkansas) recently bought shares of Roche Holding AG OTCMKTS: RHHBY. In a filing disclosed on April 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in Roche stock on March 3rd. The trade occurred in the Representative's "FISHER IRA" account.
Representative Bruce Westerman also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of LVMH Moët Hennessy - Louis Vuitton, Société Européenne OTCMKTS: LVMUY on 4/2/2025.
- Purchased $1,001 - $15,000 in shares of Sony Group NYSE: SONY on 3/24/2025.
- Purchased $1,001 - $15,000 in shares of Mitsubishi UFJ Financial Group NYSE: MUFG on 3/21/2025.
- Purchased $1,001 - $15,000 in shares of BP NYSE: BP on 3/21/2025.
- Sold $1,001 - $15,000 in shares of Procter & Gamble NYSE: PG on 3/20/2025.
- Sold $1,001 - $15,000 in shares of Medtronic NYSE: MDT on 3/20/2025.
- Purchased $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 3/20/2025.
- Sold $1,001 - $15,000 in shares of Visa NYSE: V on 3/20/2025.
- Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 3/20/2025.
- Sold $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 3/20/2025.
Roche Stock Up 0.5 %
Roche stock traded up $0.18 during midday trading on Wednesday, reaching $38.98. The stock had a trading volume of 1,442,943 shares, compared to its average volume of 3,127,018. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $44.31. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. The firm's 50-day moving average price is $40.85 and its 200 day moving average price is $38.56.
Institutional Trading of Roche
A number of hedge funds and other institutional investors have recently bought and sold shares of RHHBY. GAMMA Investing LLC increased its holdings in shares of Roche by 6,463.8% in the first quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock worth $21,759,000 after purchasing an additional 520,722 shares during the period. Boston Common Asset Management LLC raised its holdings in shares of Roche by 10.0% in the 1st quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock valued at $13,369,000 after acquiring an additional 29,522 shares in the last quarter. Altrius Capital Management Inc boosted its position in shares of Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock valued at $7,818,000 after acquiring an additional 6,545 shares during the last quarter. Bard Financial Services Inc. grew its holdings in shares of Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after purchasing an additional 28,050 shares in the last quarter. Finally, Rhumbline Advisers increased its position in shares of Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after purchasing an additional 7,374 shares during the last quarter.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. UBS Group raised shares of Roche from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 13th. Sanford C. Bernstein raised shares of Roche to a "strong-buy" rating in a report on Thursday, January 30th. Finally, Morgan Stanley began coverage on Roche in a report on Wednesday, February 12th. They issued an "equal weight" rating for the company. Two analysts have rated the stock with a sell rating, one has issued a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy".
Read Our Latest Research Report on Roche
About Representative Westerman
Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election.
Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.
About Roche
(
Get Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Articles
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
